Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma

Cetuximab, a monoclonal antibody against the epidermal growth factor receptor (EGFR), has been successfully used to treat some patients with colorectal cancer and those with head and neck squamous cell carcinoma (HNSCC). For the effective treatment, it is essential to first identify cetuximab-respon...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncogenesis
Main Authors: Kondo, T, Ozawa, S, Ikoma, T, Yang, X-Y, Kanamori, K, Suzuki, K, Iwabuchi, H, Maehata, Y, Miyamoto, C, Taguchi, T, Kiyono, T, Kubota, E, Hata, R-I
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2016
Teme:
Short Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5399171/
https://ncbi.nlm.nih.gov/pubmed/27399917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oncsis.2016.43
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki